Advancing
catheter care

Our pipeline is focused on solving long-standing challenges in catheter care and improving everyday life for people with urinary incontinence and retention.

A clear path from concept to care

In vitro

Performance is tested under controlled conditions to build early evidence and inform design development.

PHASE 01

In vivo

Selected solutions are evaluated in relevant pre-clinical models under more representative conditions.

PHASE 02

Clinical

Advanced solutions enter clinical investigation to generate evidence in the intended care setting.

PHASE 03

Development pipeline

A focused pipeline of catheter solutions spanning indwelling, intermittent and next-generation continence care.

Products
Sector
Phase 1
Phase 2
Phase 3
2nd generation Catheter Pipeline
NowCath Foley
2-way platform
Chronic & Acute care
Clinical Study
Intermittent catheter programme
Portfolio extension
Chronic care
Pre-clinical validation
NowCath 3-way
Bladder irrigation
Acute care
Pre-clinical validation
3rd generation continence care
Project Horizon
Confidential development programme
Continence care
Development

Feasibility

Early concept development, engineering and controlled bench or in-vitro evaluation.

PHASE 1

Pre-clinical validation

Design refinement, relevant in-vivo evaluation and preparation for verification and validation.

Phase 2

Clinical and regulatory

Clinical evidence generation, design verification and regulatory preparation for the intended market.

Phase 3

NowCath Foley

Designed to address residual urine.
Now being evaluated in the REDUCE clinical trial.